Gene Polymorphisms, Skin Barrier, and Inflammation in Acne

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Acne Vulgaris
Interventions
GENETIC

MMP-2 Gene Polymorphism (rs243865) Analysis

Participants were genotyped for the MMP-2 rs243865 polymorphism. Genomic DNA was extracted from peripheral blood, and the specific genotype (CC, CT, or TT) was determined using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) analysis. This allowed for the stratification of participants based on their genetic variation at this locus for subsequent association analysis.

GENETIC

TIMP-2 Gene Polymorphism (rs8179090) Analysis

Participants were genotyped for the TIMP-2 rs8179090 polymorphism. Genomic DNA was extracted from peripheral blood, and the specific genotype (CC, GC, or GG) was determined using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) analysis. This allowed for the stratification of participants based on their genetic variation at this locus for subsequent association analysis.

Trial Locations (1)

050000

Shijiazhuang TCM Hospital, Shijiazhuang

All Listed Sponsors
lead

Hong Zhang

OTHER

NCT07069075 - Gene Polymorphisms, Skin Barrier, and Inflammation in Acne | Biotech Hunter | Biotech Hunter